Abbott i-STAT CG8+ Cartridges intended for use in the in vitro quantification of potassium in art...

FDA Device Recall #Z-0615-2019 — Class II — September 13, 2018

Recall Summary

Recall Number Z-0615-2019
Classification Class II — Moderate risk
Date Initiated September 13, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Abbott Point Of Care Inc.
Location Princeton, NJ
Product Type Devices
Quantity 17550 cartridges

Product Description

Abbott i-STAT CG8+ Cartridges intended for use in the in vitro quantification of potassium in arterial, venous, or capillary whole blood. List Number/UDI# : 03P88-25 ,(01)10054749000163(17)181028(10)L18059

Reason for Recall

Inaccurate potassium results may be generated. When testing with control fluid and/or patient samples with low or reference range potassium concentration, elevated potassium results may be generated. When testing with samples with a high concentration of potassium, decreased potassium results may be generated

Distribution Pattern

WI

Lot / Code Information

Lot Number: L18059 Box Numbers: 0221, 0222, 0223, 0224, 0231, 0232, 0233

Other Recalls from Abbott Point Of Care Inc.

Recall # Classification Product Date
Z-2585-2025 Class II i-STAT EG6+ cartridge. List Number: 03P77-25. Aug 21, 2025
Z-2582-2025 Class II i-STAT CG4+ cartridge (white). List Number: 03P... Aug 21, 2025
Z-2583-2025 Class II i-STAT CG8+ cartridge. List Number: 03P88-25. ... Aug 21, 2025
Z-2584-2025 Class II i-STAT EG7+ cartridge. List Number: 03P76-25. Aug 21, 2025
Z-0880-2021 Class II Abbott i-STAT CG8+ cartridges - IVD Intended fo... Dec 22, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.